Thymidine Phosphorylase anticorps (full length)
Aperçu rapide pour Thymidine Phosphorylase anticorps (full length) (ABIN4949902)
Antigène
Voir toutes Thymidine Phosphorylase (TYMP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- Thymidine Phosphorylase Antibody / PD-ECGF (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Human recombinant full length protein was used as the immunogen for this Thymidine Phosphorylase antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Thymidine Phosphorylase antibody to be titered up or down for optimal performance.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the Thymidine Phosphorylase antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Thymidine Phosphorylase (TYMP)
-
Autre désignation
- Thymidine Phosphorylase
-
Sujet
- Recognizes a 485 amino acid protein (55 kDa monomer / 110 kDa homodimer), identified as platelet-derived endothelial growth factor (PD-ECGF), also called Thymidine Phosphorylase (TP, Tymp) or Gliostatin. In the presence of inorganic orthophosphate, it catalyzes the reversible phospholytic cleavage of thymidine and deoxyuridine to their corresponding bases and 2-deoxyribose-1-phosphate. It is both chemotactic and mitogenic for endothelial cells and a non-heparin binding angiogenic factor present in platelets. Its enzymatic activity is crucial for angiogenic activity (metabolite is angiogenic). Higher levels of serum TP/PD-ECGF are observed in cancer patients. It is also involved in transformation of fluoropyrimidines, cytotoxic agents used in the treatment of a variety of malignancies, into active cytotoxic metabolites (e.g. 5 -deoxy-5-fluorouridine to 5-FU). High intra-cellular levels of TP/PD-ECGF are associated with increased chemosensitivity to such antimetabolites.
-
UniProt
- P19971
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Antigène
-